证券代码：688272 证券简称：富吉瑞 公告编号：2025-043 北京富吉瑞光电科技股份有限公司 关于以集中竞价交易方式回购股份的预案 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 ● 回购股份用途：本次回购的股份将在未来适宜时机全部用于员工持股计划 或股权激励，并在回购完成后 3 年内予以转让。若公司未能在股份回购实施结果 暨股份变动公告日后 3 年内使用完毕已回购股份，尚未使用的已回购股份将予以 注销；如国家对相关政策作出调整，则本回购方案按调整后的政策实行。 ● 回购股份价格：本次回购股份的价格不超过人民币 38.23 元/股（含），该 价格不高于公司董事会审议通过回购股份决议前 30 个交易日公司股票交易均价的 150%。 ● 回购股份方式：通过上海证券交易所交易系统以集中竞价交易方式回购。 ● 回购股份期限：自公司董事会审议通过本次回购方案之日起不超过 12 个 月。 ● 相关股东是否存在减持计划：截至本公告披露日，公司董事、高级管理人 员、控股股东、实际控制人及一致行动人、回购股份提议人、持股 5%以上的 ...

证券代码：688272 证券简称：富吉瑞 公告编号：2025-044 北京富吉瑞光电科技股份有限公司（以下简称"公司"）第二届董事会第二 十四次会议于 2025 年 10 月 17 日在公司会议室以通讯方式召开，公司于 2025 年 10 月 14 日以邮件等方式发出了召开董事会会议的通知。本次董事会由董事 长黄富元先生主持，会议应到董事 9 名，实到董事 9 人。本次会议的召集、召 开符合有关法律、行政法规、规章、规范性文件及《北京富吉瑞光电科技股份 有限公司章程》（以下简称"《公司章程》"）、《北京富吉瑞光电科技股份有限公 司董事会议事规则》的规定，会议形成的决议合法、有效。 二、董事会会议审议情况 经与会董事审议，形成决议如下： 1、审议通过《关于以集中竞价交易方式回购公司股份的方案》 北京富吉瑞光电科技股份有限公司 第二届董事会第二十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 基于对公司未来发展的信心和对公司价值的认可，为建立完善的公司长效 激励机制，有效地将股东利益、 ...

Core Viewpoint - The company Fujirey announced a share repurchase plan with a total amount ranging from RMB 10 million to RMB 20 million, indicating a commitment to enhance shareholder value through strategic capital allocation [1] Summary by Categories Share Repurchase Plan - Fujirey plans to repurchase shares through centralized bidding, with a total repurchase amount not less than RMB 10 million and not exceeding RMB 20 million [1] - The maximum repurchase price is set at RMB 38.23 per share [1] Purpose of Repurchase - The repurchased shares will be used for employee stock ownership plans or equity incentives, with a transfer period of three years post-repurchase [1]

富吉瑞公告，拟通过集中竞价交易方式回购公司已发行的部分人民币普通股（A股）股票，预计回购金 额为1000万元-2000万元，回购资金来源为自有资金和/或自筹资金。回购股份将用于员工持股计划或股 权激励，并在回购完成后3年内予以转让。回购价格不超过38.23元/股，回购期限为董事会审议通过本 次回购方案之日起不超过12个月。 ...

格隆汇10月17日丨富吉瑞(688272.SH)公布，公司拟通过集中竞价交易方式回购公司已发行的部分人民 币普通股（A股）股票，本次回购的股份将在未来适宜时机全部用于员工持股计划或股权激励，并在回 购完成后3年内予以转让。回购股份金额不低于人民币1,000万元（含），不超过人民币2,000万元 （含）。本次回购股份的价格不超过人民币38.23元/股（含）。 ...

Core Viewpoint - Fujire (688272) announced a share buyback plan ranging from 10 million to 20 million yuan, aimed at employee stock ownership plans or equity incentives, with a maximum buyback price of 38.23 yuan per share [1] Summary by Categories - **Company Actions** - Fujire plans to repurchase shares to support employee stock ownership or equity incentive programs [1] - The buyback amount is set between 10 million and 20 million yuan [1] - The maximum price for the buyback is capped at 38.23 yuan per share [1]

Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]

Group 1 - The company, Fujiray (688272.SH), announced a proposal for share repurchase by its actual controller, controlling shareholder, chairman, and general manager, Huang Fuyuan [1] - The proposed share repurchase will utilize the company's own funds and/or self-raised funds through centralized bidding on the Shanghai Stock Exchange [1] - The total amount for the share repurchase is proposed to be no less than 10 million RMB and no more than 20 million RMB [1] Group 2 - The repurchased shares will be used for an employee stock ownership plan or equity incentive at an appropriate future time [1] - The company plans to transfer the repurchased shares within three years after the completion of the buyback [1]

Core Viewpoint - The company, 富吉瑞, announced a proposal for a share buyback plan initiated by its actual controller and major shareholder, 黄富元, with a total funding amount between 10 million and 20 million RMB [1] Group 1 - The board of directors received a proposal for the buyback on September 29, 2025 [1] - The buyback will utilize the company's own funds and/or self-raised funds through the Shanghai Stock Exchange system via centralized bidding [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives and will be transferred within three years after the buyback is completed [1]

Group 1 - The company, Fujire (688272.SH), announced a proposal for share repurchase by its actual controller, Huang Fuyuan, who is also the chairman and general manager [1] - The proposed repurchase will utilize the company's own funds and/or self-raised funds through centralized bidding on the Shanghai Stock Exchange [1] - The total amount for the share repurchase is proposed to be no less than RMB 10 million and no more than RMB 20 million [1]